The Staphylococcus aureus Chaperone PrsA Is a New Auxiliary Factor of Oxacillin Resistance Affecting

Ambre Jousselin1, Caroline Manzano2, Alexandra Biette2

  • 1Infectious Diseases Service, University Hospital and Medical School of Geneva, Geneva, Switzerland Laboratory of Bacterial Cell Biology, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.

Insights

The PrsA protein regulates methicillin-resistant Staphylococcus aureus (MRSA) by controlling the amount of PBP2A protein, a key factor in beta-lactam antibiotic resistance. This finding offers new strategies for developing anti-infective agents.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) resistance is mediated by PBP2A, encoded by mecA.
  • PBP2A has low affinity for beta-lactam antibiotics and is crucial for peptidoglycan biosynthesis.
  • The SCCmec cassette facilitates horizontal gene transfer of mecA.

Purpose of the Study:

  • Investigate the role of the membrane-bound PrsA protein in regulating beta-lactam resistance expression in MRSA.
  • Determine how PrsA affects PBP2A levels and oxacillin resistance.

Main Methods:

  • Deletion of the prsA gene in MRSA strains.
  • Quantification of PBP2A membrane levels.
  • Measurement of mecA mRNA levels.
  • Analysis of N- and C-terminal domains of PrsA.

Main Results:

  • Deletion of prsA altered oxacillin resistance across different SCCmec backgrounds.
  • prsa deletion decreased PBP2A membrane protein levels without affecting mecA mRNA.
  • Specific domains of PrsA were critical for PBP2A membrane levels and resistance.

Conclusions:

  • PrsA acts as a regulator of beta-lactam resistance by influencing PBP2A levels post-transcriptionally.
  • PrsA may be involved in the maturation, export, or folding of PBP2A.
  • Targeting PrsA offers a novel strategy for developing anti-MRSA agents.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
78
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
29
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
53
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
46
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
39